InMode (INMD) Profit After Tax Growth (3y) (2021 - 2026)
Powered by 
Analysis
InMode (INMD) Profit After Tax Growth (3y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | -12.28% |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 21.98% |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 22.89% |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 20.02% |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 49.66% |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | -7.65% |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | - |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 29.05% |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | 15.46% |
| 10 | InMode | 944.68 Mn | 462.56 Mn | 71.52 Mn | -32.60% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -32.60% |
| Mar 31, 2026 | -34.16% |
| Dec 31, 2025 | -10.51% |
| Sep 30, 2025 | -23.48% |
| Jun 30, 2025 | -15.32% |
| Mar 31, 2025 | -16.24% |
| Dec 31, 2024 | 16.25% |
| Sep 30, 2024 | 4.47% |
| Jun 30, 2024 | -16.51% |
| Mar 31, 2024 | -3.96% |
| Dec 31, 2023 | 15.21% |
| Sep 30, 2023 | 24.89% |
| Jun 30, 2023 | 86.58% |
| Mar 31, 2023 | 84.11% |
| Dec 31, 2022 | 25.73% |
| Sep 30, 2022 | 44.43% |
| Jun 30, 2022 | 40.64% |
| Mar 31, 2022 | 45.01% |
| Dec 31, 2021 | 529.41% |
| Sep 30, 2021 | 72.99% |